Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -0.64 is 383% below its 5-year average of 0.23, near the high end of its 5-year range (-26.80–7.04).
As of the fiscal period ended Tuesday, June 30, 2026. 89.22% above its 12-month average of -5.92.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -0.64.
DEBT TO EQUITY RATIO
-0.64
DEBT TO EQUITY RATIO AVG TTM
-5.92
DEBT TO EQUITY RATIO AVG 3Y
-0.58
DEBT TO EQUITY RATIO AVG 5Y
0.23
DEBT TO EQUITY RATIO AVG 10Y
0.03
DEBT TO EQUITY RATIO AVG 15Y
0.02
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+89.22%
CURRENT VS 3Y AVG
-10.22%
CURRENT VS 5Y AVG
-383.05%
CURRENT VS 10Y AVG
-2163.32%
CURRENT VS 15Y AVG
-3483.84%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.13
median of 525 covered companies
CURRENT VS SECTOR MEDIAN
-591.23%
vs the sector median at left
Market Cap
$3.53M
Debt to Equity Ratio
7.21
TTM Avg
1.21
3Y Avg
0.62
5Y Avg
0.62
Market Cap
$3.35M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$3.40M
Debt to Equity Ratio
0.07
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.08
Market Cap
$3.34M
Debt to Equity Ratio
0.01
TTM Avg
0.05
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$3.04M
Debt to Equity Ratio
N/A
TTM Avg
1.28
3Y Avg
1.28
5Y Avg
0.64
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.52M | -0.64 | -5.92 | -0.58 | 0.23 |
| Mustang Bio, Inc. (MBIO)vs › | $3.53M | 0.00 | 0.00 | 7.00 | 4.21 |
| Moolec Science S.A. (MLEC)vs › | $3.53M | 7.21 | 1.21 | 0.62 | 0.62 |
| Eocene Ltd. (EOCN)vs › | $3.60M | N/A | N/A | N/A | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.35M | 0.00 | 0.00 | 0.00 | 0.00 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.40M | 0.07 | 0.10 | 0.11 | 0.08 |
| IceCure Medical Ltd (ICCM)vs › | $3.34M | 0.01 | 0.05 | 0.04 | 0.04 |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 0.00 | 0.00 | 0.01 | 0.01 |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.04M | N/A | 1.28 | 1.28 | 0.64 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.06M | 0.70 | 0.62 | 0.55 | 2.94 |
Debt/Equity
-0.64
Current Ratio
3.57
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -0.64 |
| 2026-03-31 | -0.80 |
| 2025-12-31 | -26.80 |
| 2025-09-30 | 2.21 |
| 2025-06-30 | -3.57 |
| 2025-03-31 | -3.56 |
| 2024-12-31 | -8.87 |
| 2024-09-30 | -2.53 |
| 2024-06-30 | 7.04 |
| 2024-03-31 | 1.37 |
| 2023-12-31 | 0.95 |
| 2023-09-30 | 0.62 |
| 2023-06-30 | 0.83 |
| 2023-03-31 | 0.54 |
| 2022-12-31 | 0.43 |
| 2022-09-30 | 0.39 |
| 2022-06-30 | 0.06 |
| 2022-03-31 | 0.05 |
| 2021-12-31 | 0.05 |
| 2021-09-30 | 0.04 |
| 2021-06-30 | 0.04 |
| 2021-03-31 | 0.03 |
| 2020-12-31 | 0.05 |
| 2020-09-30 | 0.05 |
| 2020-06-30 | 0.07 |
| 2020-03-31 | 0.06 |
| 2019-12-31 | 0.06 |
| 2019-09-30 | 0.06 |
| 2019-06-30 | 0.08 |
| 2019-03-31 | 0.07 |
| 2018-12-31 | 0.00 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.00 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.00 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.00 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
